Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gut Permeability with Oral Typhoid Vaccine
NCT04083950Phase 1Active, not recruiting
- Sponsor
- Western Human Nutrition Research Center
- Start
- Dec 2019
- Primary completion
- Jan 2022
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of typhoid vaccine, live oral in typhoid fever, sponsored by Western Human Nutrition Research Center. Primary endpoint: Change in intestinal permeability at Day 22. Started Dec 2019; status: active, not recruiting.
02
Drugs
typhoid vaccine, live oral
03
Conditions
typhoid fever
Beyond the preview
Go deeper on NCT04083950.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04083950.